Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Nelitolimod sodium by TriSalus Life Sciences for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Nelitolimod sodium is under clinical development by TriSalus Life Sciences and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According...
Nelitolimod sodium by TriSalus Life Sciences for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Nelitolimod sodium is under clinical development by TriSalus Life Sciences and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma)....
Nelitolimod sodium by TriSalus Life Sciences for Hepatocellular Carcinoma: Likelihood of Approval
Nelitolimod sodium is under clinical development by TriSalus Life Sciences and currently in Phase II for Hepatocellular Carcinoma. According to...